The pancreatic duct gland (PDG) compartment has been proposed as a potential stem 23 cell niche based on its coiled tubular structure embedded in mesenchyme, its 24 proliferation and expansion in response to pancreatic injury, and the fact that it contains 25 endocrine and exocrine epithelial cells. Little is known of the molecular signature of the 26 PDG compartment in either a quiescent state or the potentially activated state during 27 beta cell stress characteristic of diabetes. To address this, we performed RNA 28 
4

INTRODUCTION 58
It has been known for many years that there are glandular-like structures arising from 59 larger pancreatic ducts that undergo proliferation following pancreatic injury with an 60 increase in cells expressing the transcription factor Pdx-1, and containing occasional 61 endocrine cells (22, 23) . More recently, these glandular structures were proposed as 62 being a distinct anatomic compartment with molecular features consistent with a stem 63 cell niche, and named pancreatic duct glands (PDGs) (20) . PDGs are crypt-like 64 invaginations off the pancreatic ductal tree, embedded in mesenchyme and as such are 65 anatomically reminiscent of the gastric, ileal and colonic crypt stem cell niches ( Figure  66 1) (3). Similar glandular structures (peribiliary glands) are present as crypt-like 67 outpouches off the biliary tree and have been reported to bear multiprogenitor cells with 68 a potential ductal epithelium or endocrine fate (8). PDGs, like ileal crypts, have zones of 69 increased replication, consistent with a transit amplifying zone, and a predominance of 70 exocrine epithelial cells with a minority of endocrine cells. The PDG compartment is 71 expanded with increased proliferation in humans with both type 1 diabetes (17) and type 72
diabetes (19). 73 74
Relatively little is known about the molecular signature of PDGs. Thus far, molecular 75 characterization of PDGs has relied on candidate immunohistochemistry or RT-PCR in 76 rats or mice (20, 22, 23) and immunohistochemistry in humans (17). To date this 77 approach has revealed Pdx-1, nestin, mucin-6, Hes1 and Ngn3 expression in rodent 78
5
Powerful new tools are available to characterize the molecular signatures of tissues of 81 interest based on RNA and/or protein profiling. Laser capture microdissection (LCM) is 82 a technique that enables isolation of RNA and/or protein from a compartment of interest 83 within an organ. After identification of the compartment by microscopy, laser dissection 84 is used to procure a sample of the cells of interest to permit subsequent gene 85 expression and/or proteome profiling (11, 21) . In the present study we employed that 86 approach to procure high quality RNA by a protocol validated for PDGs (7). We then 87 characterized the transcriptional profile of these samples using RNA sequencing (RNA-88 seq) to establish the molecular identity of the PDG compartment in an unbiased 89 manner. We used these data 1) to compare the molecular signature of PDGs to that of 90 multiple tissues; 2) to identify possible markers overrepresented in the PDG 91 compartment; and 3) to compare PDG samples from a rat model of type 2 diabetes (HIP 92 rat) compared to wild type controls, with the goal of identifying the signaling networks 93 and pathways altered in PDGs in the context of diabetes. 94
95
MATERIALS AND METHODS 96
Rats. The generation of the human IAPP transgenic rats (HIP) has been described in 97 detail previously (5). Wild type rats were littermates of HIP rats. Rats were bred at the 98 University of California, Los Angeles (UCLA) animal housing facility and subjected to a 99 standard 12-h light-dark cycle and were fed Rodent Diet 8604 (Harlan Teklad, Madison, 100 WI) ad libitum. All experimental procedures were approved by the UCLA Institutional 101
Animal Care and Use Committee. HIP rats develop overt diabetes between 9 and 12 102 months of age with islet pathology similar to humans with type 2 diabetes, specifically 103 6 ongoing beta cell apoptosis with a progressive defect in beta cell mass (5). HIP rats 104 used for this study were ~6 months of age, and so prediabetic with ongoing beta cell 105 apoptosis but without the confounding secondary actions of hyperglycemia on gene 106 expression (15). WT rats were age-matched. 107
108
Tissue procurement and LCM. On the day of study, animals were anesthetized by 109 inhalation of isoflurane (Abbott Laboratories, Chicago, IL). Rat pancreas was rapidly 110 dissected, divided into two portions (head and body of pancreas, and tail of pancreas), 111 and cryopreserved in Optimal Cutting Temperature (OCT) compound (7). 10-15 112
Sections were cut from the head of the pancreas for each LCM experiment. In brief, 113 eight micrometer sections were mounted on UV irradiated polyethylene naphthalate 114 (PEN) membrane slides and stored at -80 o C. Right before use, slides were fixed in 115 alcohol and stained with hematoxylin (solutions contained RNA inhibitors). 116
117
The PDG compartment was identified morphologically. As described in (20, 24) , the 118 PDG compartment is readily identifiable in mouse and human pancreas due to its 119 unique architecture distinct from the ductal epithelium. We confirmed previously that 120 similar to humans and mice, PDGs in rat pancreatic tissue sections appear as coiled 121 structures embedded in the mesenchyme surrounding the main duct, and are readily 122 stained with Alcian blue and p-aminosalicylic acid, and also characterized by the 123 increased proliferation rate relative to normal ductal cells (12). For current study we set 124 out to collect only PDGs in the substantial layer of mesenchyme where, based on 125 7 extensive experience (6, 12, 17, 19) http://www.semel.ucla.edu/ungc). Between 5-20 ng of total RNA were extracted per 157 tissue. After quantification and quality check, 5 ng of total RNA were amplified at UNGC 158 using the NuGEN Ultralow Library System kit (NuGEN), which is optimized for 159 downstream Illumina library preparation. We extracted RNA from 6 samples: 3 from HIP 160 and 3 from WT animals. Illumina RNA-seq libraries were then prepared according to 161 manufacturer's instructions. Sequencing was performed using the Illumina HiSeq 2500 162 sequencer and the v3 Illumina chemistry. We barcoded multiple samples and ran them 163 over multiple lanes, in order to minimize batch effects (2). We ran the equivalent of 3 164 samples per lane, with paired-end 100bp read length, corresponding to 2 HiSeq 2500 165
lanes. 166 167
Between 83 and 187 million, 100 basepair long, paired-end reads were obtained and 168 aligned to the rat genome (rn5) using the STAR spliced read aligner (10). 65-72% reads 169 mapped uniquely to the rat genome, and ~50% of the genes in the rat genome were 170 detected as present by at least 100 mapping reads. Samples were clustered using 171 9 hierarchical clustering and multidimensional scaling (MDS), and no outliers were 172 detected. 173 174 Data Analysis. An RNA-Seq pipeline is established in the UCLA Informatics Center for 175
Neurogenetics and Neurogenomics (https://github.com/icnn/RNAseq-PIPELINE.git). 176
Initial analysis steps included: 1) Quality analysis, alignment to reference genome using 177 STAR (10), and filtering of reads not uniquely mapping or mapping to repetitive regions; 178 2) Mapping of reads to exons, untranslated regions (UTRs) and intron-exon junctions 179 using STAR, and generation of RefSeq isoform counts; 3) Normalization and differential 180 expression analysis by tissue and condition using the software DEseq (1) and edgeR 181 (18); 4) Data upload onto our web-based gene expression database. 182
183
Multidimensional scaling (MDS) was used to cluster PDG samples with samples 184 obtained from an atlas of gene expression in human tissues. Briefly, the human GNF 185 database was downloaded from the bioGPS website (http://biogps.org), probes 186 targeting transcripts shared across the two platforms (Affymetrix, used in the GNF 187 database and RNA-seq, used in this study) were normalized jointly using quantile 188 normalization and MDS plots were generated to organize samples in a 2-dimensional 189 space, based on the expression of the top 1000 most variable genes. Differential Having previously established a method to obtain RNA by LCM from PDGs of a suitable 210 quality and confirmed to reflect the PDG compartment based on RT-PCR of sentinel 211 genes (7), we applied this approach here to obtain RNA from PDGs to perform RNA-212 seq so as to obtain an unbiased genetic expression profile of the PDG compartment. 213 With these data, we then compared the PDG transcriptome to an atlas of transcriptional 214 data including 84 tissues. MDS analysis (see Methods, Figure 3 legend) clustered 215 related tissues (e.g. brain regions, or blood cell types) together due to similarity of their 216 transcriptome. Our PDG samples were placed in a region including other pancreatic 217 samples (both exocrine and endocrine), further supporting their source tissue of origin, 218 but also testis (including seminiferous tubules, which host actively replicating cells with 219 pluripotent potential), and pituitary gland (Figure 3) . 220
221
We then proceeded to identify the markers most specific to the PDG compartment. 222
Briefly, after normalization we compared the all six PDG samples to the average of all 223 other tissues in the GNF database. This analysis identified 22 transcripts as putatively 224 overexpressed in PDG cells relative to the average expression levels of 84 tissues 225 (p<0.005, Table 1 ). Finally, we compared PDG expression profiles between HIP and 226 WT rats (Table 2) . Standard differential expression analysis at a permissive threshold 227 (p<0.005) identified 245 genes ( Figure 4A , 4B), which were differentially expressed 228 across the three replicates. Gene Ontology analysis ( Figure 4C ) highlighted an 229 overrepresentation of transcripts involved in acute inflammatory response, regulation of 230 cell proliferation, and tissue development. Pathway analysis pointed to enrichment of 231 cell movement-related pathways, and the top 2 networks ( Figure 5A , 5B) included 232 ADIPOQ, playing an important role in type 2 diabetes, and the known therapeutic target 233
PPARG. 234 235
In conclusion, unbiased transcriptional analyses support the notion that the PDG 236 compartment includes a unique transcriptional niche, similar to both the tissue of origin 237 (pancreas) and to replicating cells, and that a signal related to diabetes is detectable in 238 a rat model of type 2 diabetes. 239
DISCUSSION 241
While the existence of blind pouches from main pancreatic ducts bearing stem cell 242 markers has been appreciated for many years, only recently has this anatomical 243 compartment been named the pancreatic duct gland (PDG) compartment and been 244
proposed as a stem cell niche responsible for repair of pancreas following acute injury 245 (9). This raises the possibility that the PDG compartment might not only serve to repair 258 exocrine ductal tissue as already reported, but also be a potential source of pancreatic 259 endocrine cells, although no effective beta cell formation from the PDG compartment 260 was identified in humans with type 1 or 2 diabetes (17, 19) . 14 Modeling studies applied to the HIP rat model of type 2 diabetes revealed an adaptive 285 increase in beta cell formation not attributable to beta cell replication (14). Therefore, we 286 selected this model of type 2 diabetes to investigate the PDG transcriptome for 287 evidence of adaptive changes that might be expected in a relevant stem cell niche. 288
Differential gene expression analysis between PDGs from HIP and WT rats were 289 consistent with tissue stem cell response to injury in a relevant compartment. For 290 example the most significant alteration was in genes engaged in inflammatory 291
responses. This implies communication between injured pancreatic islets and PDGs, 292 presumably either through the known intrapancreatic portal venous system or through 293 the rich intrapancreatic neural network. Also, given the well-recognized role that 294 inflammatory pathways play in the induction of tissue repair, it is of interest that PDGs in 295 HIP rats not only apparently sense and respond to pancreatic islet inflammation, but 296 also that regulation of cell proliferation and tissue development genes are also highly 297 represented in the PDG transcriptome of HIP rats compared to non-diabetic WT rats. 298
Pathway analysis also pointed to enrichment of cell movement-related pathways, and 299 the top 2 networks ( Figure 5A , 5B) included ADIPOQ, a gene with known linkage to 300 obesity and type 2 diabetes, and the therapeutic target in type 2 diabetes, PPARG. The 301 PDG compartment has been reported to be expanded with increased proliferation in 302 humans with both type 1 and 2 diabetes, and this is reproduced in the HIP rat model 303 (17, 19). Here we now report the transcriptome of the PDG is consistent with a tissue 304 stem cell niche serving both the exocrine and endocrine pancreas, and undergoing 305 
